Literature DB >> 19470579

IP-10 induces dissociation of newly formed blood vessels.

Richard J Bodnar1, Cecelia C Yates, Margaret E Rodgers, Xiaoping Du, Alan Wells.   

Abstract

The signals that prune the exuberant vascular growth of tissue repair are still ill defined. We demonstrate that activation of CXC chemokine receptor 3 (CXCR3) mediates the regression of newly formed blood vessels. We present evidence that CXCR3 is expressed on newly formed vessels in vivo and in vitro. CXCR3 is expressed on vessels at days 7-21 post-wounding, and is undetectable in unwounded or healed skin. Treatment of endothelial cords with CXCL10 (IP-10), a CXCR3 ligand present during the resolving phase of wounds, either in vitro or in vivo caused dissociation even in the presence of angiogenic factors. Consistent with this, mice lacking CXCR3 express a greater number of vessels in wound tissue compared to wild-type mice. We then hypothesized that signaling from CXCR3 not only limits angiogenesis, but also compromises vessel integrity to induce regression. We found that activation of CXCR3 triggers micro-calpain activity, causing cleavage of the cytoplasmic tail of beta3 integrins at the calpain cleavage sites c'754 and c'747. IP-10 stimulation also activated caspase 3, blockage of which prevented cell death but not cord dissociation. This is the first direct evidence for an extracellular signaling mechanism through CXCR3 that causes the dissociation of newly formed blood vessels followed by cell death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470579      PMCID: PMC2723158          DOI: 10.1242/jcs.048793

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  40 in total

1.  The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts.

Authors:  Andreas Kouroumalis; Robert J Nibbs; Herve Aptel; Karen L Wright; George Kolios; Stephen G Ward
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

2.  Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells.

Authors:  Elizabeth D Feldman; David M Weinreich; Nancy M Carroll; Monika L Burness; Andrew L Feldman; Ewa Turner; Hui Xu; H Richard Alexander
Journal:  Ann Surg Oncol       Date:  2006-01-01       Impact factor: 5.344

3.  Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.

Authors:  Latha Satish; Harry C Blair; Angela Glading; Alan Wells
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

4.  Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts.

Authors:  T Tsubaki; S Takegawa; H Hanamoto; N Arita; J Kamogawa; H Yamamoto; N Takubo; S Nakata; K Yamada; S Yamamoto; O Yoshie; M Nose
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

5.  Tyrosine phosphorylation of the integrin beta 3 subunit regulates beta 3 cleavage by calpain.

Authors:  Xiaodong Xi; Panagiotis Flevaris; Aleksandra Stojanovic; Athar Chishti; David R Phillips; Stephen C T Lam; Xiaoping Du
Journal:  J Biol Chem       Date:  2006-08-25       Impact factor: 5.157

Review 6.  Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors.

Authors:  George E Davis; W Brian Saunders
Journal:  J Investig Dermatol Symp Proc       Date:  2006-09

Review 7.  CXCR3-binding chemokines: novel multifunctional therapeutic targets.

Authors:  E Lazzeri; P Romagnani
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2005-03

8.  WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature.

Authors:  Ivan B Lobov; Sujata Rao; Thomas J Carroll; Jefferson E Vallance; Masataka Ito; Jennifer K Ondr; Savita Kurup; Donald A Glass; Millan S Patel; Weiguo Shu; Edward E Morrisey; Andrew P McMahon; Gerard Karsenty; Richard A Lang
Journal:  Nature       Date:  2005-09-15       Impact factor: 49.962

Review 9.  Endogenous inhibitors of angiogenesis.

Authors:  Pia Nyberg; Liang Xie; Raghu Kalluri
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

10.  IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain.

Authors:  Richard J Bodnar; Cecelia C Yates; Alan Wells
Journal:  Circ Res       Date:  2006-02-16       Impact factor: 17.367

View more
  61 in total

1.  Sprouty2 downregulates angiogenesis during mouse skin wound healing.

Authors:  Mateusz S Wietecha; Lin Chen; Matthew J Ranzer; Kimberly Anderson; Chunyi Ying; Tarun B Patel; Luisa A DiPietro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

2.  m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate.

Authors:  Ludovic Leloup; Hanshuang Shao; Yong Ho Bae; Bridget Deasy; Donna Stolz; Partha Roy; Alan Wells
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 3.  Chemokine Regulation of Angiogenesis During Wound Healing.

Authors:  Richard J Bodnar
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 4.  Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds.

Authors:  Latha Satish
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 5.  Skin tissue repair: Matrix microenvironmental influences.

Authors:  Alan Wells; Austin Nuschke; Cecelia C Yates
Journal:  Matrix Biol       Date:  2015-08-14       Impact factor: 11.583

Review 6.  CXCR3 in carcinoma progression.

Authors:  Bo Ma; Ahmad Khazali; Alan Wells
Journal:  Histol Histopathol       Date:  2015-02-09       Impact factor: 2.303

Review 7.  Therapeutic Approaches to the Regulation of Wound Angiogenesis.

Authors:  Mateusz S Wietecha; Luisa A DiPietro
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-04       Impact factor: 4.730

Review 8.  The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing.

Authors:  Arthur C Huen; Alan Wells
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-12       Impact factor: 4.730

9.  Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression.

Authors:  Ye Bi; Venktesh S Shirure; Ruiyang Liu; Cassandra Cunningham; Li Ding; J Mark Meacham; S Peter Goedegebuure; Steven C George; Ryan C Fields
Journal:  Integr Biol (Camb)       Date:  2020-09-30       Impact factor: 2.192

Review 10.  CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.

Authors:  Zahra Ahmadi; Mohammad Kazemi Arababadi; Gholamhossin Hassanshahi
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.